Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alfacell signs Onconase distribution agreement with Megapharm
Under the agreement, Alfacell has granted Megapharm exclusive rights in the defined territory for the marketing, sales and distribution of Onconase. Alfacell will receive 50% of all sales
Under the agreement, Alfacell has granted Megapharm exclusive rights in the defined territory for the marketing, sales and distribution of Onconase. Alfacell will receive 50% of all sales
ThermaCare will join the company’s pain franchise that includes Advil – one of the world’s leading oral pain relievers – and will enhance Wyeth’s global position in pain
The expanded partnership will give researchers at Mitsubishi Tanabe preferred access to Metabolon’s global biochemical profiling services. Completing research studies using Metabolon’s services, Mitsubishi Tanabe has gained insight
Genentech’s Activase, a recombinant tissue plasminogen activator is approved for the management of acute ischemic stroke in adults. Through this agreement, the companies will collaborate and Genentech will
Remedi SeniorCare, formerly Woodhaven Health Services, will now serve more than 20,000 residents in Maryland, Delaware, Washington DC, Virginia, Ohio, Kentucky, Indiana and Michigan. All Remedi SeniorCare customers
Technology4Medicine will sell MedX Health’s newest laser product, Oralase immediately upon clearances from the FDA to dental offices. Oralase is said to be a low level laser therapy
The investment and collaboration will help support continued development of Abeome’s lead ovarian cancer project. Abeome’s proprietary technology improves the development of monoclonal antibodies and Abeome is deploying
This Phase II double-blind study (study RX-3341-201) will evaluate the safety and efficacy of RX-3341 at two different doses administered intravenously to hospitalized complicated skin and skin structure
CHDI researchers will be able to leverage this knowledge using the complete set of analysis tools and structured knowledge already available in IPA. This new type of solution
Medtronic’s Reveal DX insertable cardiac monitor (ICM) has been designated by the Japanese government as a high-priority medical device, and is said to be the first insertable cardiac